Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic signature and immune landscape of 5-methylcytosine-related long non-coding RNAs in gastric cancer

1 Sept 2024

Abstract excerpt

Background: Long non-coding RNAs (lncRNAs) have been demonstrated to be useful in assessing the prognosis of cancer patients. However, few studies have focused on 5-methylcytosine-related lncRNAs (m5C-lncRNAs) in gastric cancer (GC). In this study, we aimed to establish a m5C-lncRNAs prognostic signature (m5C-LPS) and explore its potential impact on guiding clinical practice for GC. Methods: RNA-sequence and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39323814
DOI: 10.1016/j.heliyon.2024.e37290

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic signature and immune landscape of 5-methylcytosine-related long non-coding RNAs in gastric cancerPMID 39323814Read ↗

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAsSemantic proximity Read ↗

Novel M7G-Related lncRNA Signature for Predicting Overall Survival in Patients with Gastric CancerSemantic proximity Read ↗

N6-methyladenosine demethylase FTO serves as an indicator for predicting prognosis and immunotherapy response in individuals with gastric cancerSemantic proximity Read ↗

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancerSemantic proximity Read ↗

Efferocytosis-Related LncRNA Signatures for Predicting Prognosis and Immune Landscape of Gastric CancerSemantic proximity Read ↗

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerSemantic proximity Read ↗

Identification of Prognosis Signature and Analysis of the Immune Microenvironment in Gastric Cancer Based on ALKBH5Semantic proximity Read ↗

Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related lncRNAs in Gastric CancerSemantic proximity Read ↗

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patientsSemantic proximity Read ↗

Identification and validation of a novel redox- related differentially expressed lncRNA prognostic signature for predicting clinical immunotherapy response in gastric cancerSemantic proximity Read ↗

Identification of a novel pyroptosis related long noncoding RNA subtypes, development of a prognostic model and characteristics of the tumor microenvironment in gastric cancerSemantic proximity Read ↗

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.